These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 11049785)

  • 1. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii.
    Surawicz CM; McFarland LV; Greenberg RN; Rubin M; Fekety R; Mulligan ME; Garcia RJ; Brandmarker S; Bowen K; Borjal D; Elmer GW
    Clin Infect Dis; 2000 Oct; 31(4):1012-7. PubMed ID: 11049785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii.
    Surawicz CM; McFarland LV; Elmer G; Chinn J
    Am J Gastroenterol; 1989 Oct; 84(10):1285-7. PubMed ID: 2679049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of recurrent Clostridium difficile-associated disease.
    Surawicz CM
    Nat Clin Pract Gastroenterol Hepatol; 2004 Nov; 1(1):32-8. PubMed ID: 16265042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease.
    McFarland LV; Surawicz CM; Greenberg RN; Fekety R; Elmer GW; Moyer KA; Melcher SA; Bowen KE; Cox JL; Noorani Z
    JAMA; 1994 Jun 22-29; 271(24):1913-8. PubMed ID: 8201735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recurrent Clostridium difficile enterocolitis].
    Bergamin B; Hess T; Jost R; Ballmer PE; Imoberdorf R
    Schweiz Med Wochenschr; 2000 Nov; 130(44):1681-4. PubMed ID: 11103440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saccharomyces boulardii for the treatment of Clostridium difficile-associated colitis.
    Eddy JT; Stamatakis MK; Makela EH
    Ann Pharmacother; 1997; 31(7-8):919-21. PubMed ID: 9220059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease.
    McFarland LV; Elmer GW; Surawicz CM
    Am J Gastroenterol; 2002 Jul; 97(7):1769-75. PubMed ID: 12135033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
    Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ
    Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study.
    Can M; Beşirbellioglu BA; Avci IY; Beker CM; Pahsa A
    Med Sci Monit; 2006 Apr; 12(4):PI19-22. PubMed ID: 16572062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial.
    Kotowska M; Albrecht P; Szajewska H
    Aliment Pharmacol Ther; 2005 Mar; 21(5):583-90. PubMed ID: 15740542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile-associated disease.
    Heins JR
    S D Med; 2006 Dec; 59(12):515-7. PubMed ID: 17212182
    [No Abstract]   [Full Text] [Related]  

  • 12. [Relapsing infections with Clostridium difficile].
    Visser WE; Dingemans-Dumas AM; Bac DJ
    Ned Tijdschr Geneeskd; 2005 Oct; 149(43):2381-5. PubMed ID: 16277125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolution of recurrent Clostridium difficile-associated diarrhea using staggered antibiotic withdrawal and kefir.
    Bakken JS
    Minn Med; 2009 Jul; 92(7):38-40. PubMed ID: 19708314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The approach to recurrent infections with Clostridium difficile].
    Paz Z; Altman A
    Harefuah; 2008 Nov; 147(11):864-5, 942. PubMed ID: 19264004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial.
    Pozzoni P; Riva A; Bellatorre AG; Amigoni M; Redaelli E; Ronchetti A; Stefani M; Tironi R; Molteni EE; Conte D; Casazza G; Colli A
    Am J Gastroenterol; 2012 Jun; 107(6):922-31. PubMed ID: 22472744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea.
    Wilcox MH
    J Antimicrob Chemother; 2004 May; 53(5):882-4. PubMed ID: 15073160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease.
    McFarland LV
    Am J Gastroenterol; 2006 Apr; 101(4):812-22. PubMed ID: 16635227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment strategies for C. difficile associated diarrhea.
    Stepan C; Surawicz CM
    Acta Gastroenterol Latinoam; 2007 Sep; 37(3):183-91. PubMed ID: 17955730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.
    Johnson S
    J Infect; 2009 Jun; 58(6):403-10. PubMed ID: 19394704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
    Zar FA; Bakkanagari SR; Moorthi KM; Davis MB
    Clin Infect Dis; 2007 Aug; 45(3):302-7. PubMed ID: 17599306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.